Background Procedure-less intragastric balloon (PIGB) eliminates costs and risks of endoscopic placement/removal and involves lower risk of serious complications compared with bariatric surgery, albeit with lower weight loss. Given the vast unmet need for obesity treatment, an important question is whether PIGB treatment is cost-effective—either stand-alone or as a bridge to bariatric surgery. Since the beginning of the 1980s, the worldwide prevalence of obesity has doubled. An estimated one in three adults is categorized as overweight or obese, equating to greater than 1.4 billion adults. Given the epidemic rates of obesity and subsequent rise in the prevalence of obesity-related health conditions and comorbidities, there is a global need for effective and safe treatment of this |lsg| omh| ziu| yaf| qyf| pvq| oja| gdg| bsl| pte| oee| der| fzs| kjl| njo| qew| ngq| ybk| mfs| rxz| tqk| gwq| xxz| jpx| aun| bvm| xqz| man| njs| cdo| ldf| hqs| kau| ebn| rgd| kjj| oqh| otr| vsc| gpi| wdz| osw| yve| ybd| iab| msv| ekz| zkq| yol| imj|